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Abstract
Aortic root dilation (AoD) imparts increased risk of aortic complications such as 
dissection, rupture, and valvular regurgitation. Multiple etiologies of AoD exist, such 
as Marfan syndrome, bicuspid aortic valve, Ehler-Danlos syndrome, infections, and 
idiopathic conditions. Due to the variety of clinical conditions that can result in AoD, 
and the risks associated with worsening AoD, a thorough understanding of the patho-
physiology of AoD, noninvasive imaging modalities, and pharmacologic therapies is 
critical. This chapter will review the various etiologies of AoD, pathophysiological basis 
of each disease entity, overview of the diagnosis of AoD, noninvasive imaging modalities 
employed for detection and surveillance, pharmacological therapies used in the preven-
tion and management, and the factors that guide intervention such as surgical repair.
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1. Introduction
Aortic root dilation (AoD) is frequently an incidentally discovered, asymptomatic 
finding in that is seen on various imaging modalities [1]. The anatomy of the aortic 
root includes the annulus, sinuses of Valsalva, sinotubular junction and ascending 
aorta [1], with the size being a function of a patient’s biologic variables such as height, 
age, BSA, and gender [1, 2]. However, while natural variations in the size of the aortic 
root are well known, the identification of progression from normal to pathologic AoD 
is a key clinical diagnosis that carries significant cardiovascular risk including aortic 
dissection, rupture, valvular regurgitation and cardiac tamponade [1, 3–5]. The etiol-
ogy of pathological AoD is varied, ranging from congenital, infectious, autoimmune, 
and idiopathic conditions; and influences the medical and surgical management 
[1, 5]. Due to the variety of clinical conditions that can result in AoD, and the risks 
associated with worsening AoD, a thorough understanding of the pathophysiology 
of AoD, noninvasive imaging modalities and pharmacologic therapies is critical. The 
aim of this chapter is to review the most common conditions associated with AoD, 
appropriate imaging modalities, and treatment strategies to manage AoD.
2. Etiologies of aortic root dilation
Multiple etiologies of AoD exist such as Marfan syndrome, bicuspid aortic valve, 
Loeys-Dietz and Ehler-Danlos syndromes, idiopathic conditions, hypertension, 
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infections, and inflammatory disorders. In this chapter, we will discuss the various 
etiologies categorized into two standardized groups—genetically-mediated and 
nongenetically mediated AoD.
2.1 Genetically-mediated aortic root dilation
Genetically-mediated aortic root dilation or enlargement is the leading cause of 
thoracic aortic aneurysms. Marfan syndrome (MFS), the prototype condition for 
AoD, and bicuspid aortic valve has led to a greater understanding of AoD patho-
physiology, pharmacologic treatment, timing of surgical intervention and optimal 
surveillance strategies with noninvasive imaging [6].
2.1.1 Marfan syndrome
MFS is one of the most common hereditary disorders of connective tissues and is 
characterized by manifestations in cardiovascular, skeletal, and ocular systems [7]. 
MFS is the most common genetic cause of thoracic aortic aneurysms (TAAs). Its 
inheritance is almost exclusively autosomal dominant and mostly involves a muta-
tion of the fibrillin-1 (FBN1) gene encoding the connective tissue structural protein 
fibrillin-1 [8]. The widely accepted incidence of Marfan syndrome is ~1 in 5000 
individuals [9].
Although the inheritance pattern is predominantly autosomal dominant, rare 
cases of autosomal recessive FBN1 gene mutations has been described [10]. While 
patients with Marfan phenotypes usually have an affected family member, 25% 
of the cases are sporadic due to de novo mutations [9]. In addition, in <10% of 
Marfan cases, no mutation of FBN1 was determined [11]. Since it was first identi-
fied as the main cause of Marfan syndrome, FBN1 mutations, depending on how 
it is mutated, were linked to a variety of syndromes and phenotypes [12]. Animal 
studies investigating the pathophysiology of the disease demonstrated over-
expression of TGF-β in the mitral valve preceding prolapse, the aorta associated 
with dilatation, skeletal muscle associated with myopathy, and the dura leading 
to ectasia [12]. Later, mutations in TGF-beta receptor 2 (TGFBR2) and TGFBR1 
genes were identified in some patients with Marfan phenotypes and subsequently 
implicated in the disease process in FBN1 mutation negative individuals [13–15]. 
These genes were also linked to another condition later, namely Loeys-Dietz 
syndrome (LDS) [14].
The diagnosis of Marfan syndrome is established by using a combination of 
clinical manifestations, family history, and the presence of FBN1 mutation. In order 
to facilitate accurate recognition of the syndrome and improve patient manage-
ment and counseling, a set of defined clinical criteria, called the Ghent nosology 
was developed [16] and later revised [17] (Table 1). Apart from the genetic testing 
for FBN1 mutation, Ghent nosology uses a systemic score calculation using clinical 
manifestations of Marfan and an aortic root dilatation Z-score (see noninvasive 
imaging below).
One of the major causes of mortality and clinical hallmark of Marfan syndrome 
is aortic root dilation and related complications such as dissection, rupture and/
or aortic valvular regurgitation. Aortic root dilation is typically first identified 
on echocardiography in 60–80% of Marfan patients [18]. Therefore, surveillance 
echocardiography has been routinely used to serially monitor aortic dimensions. 
If the aortic root diameter is above 4.5 cm in adults, aortic dilation rates are above 
0.5 cm/year, and/or significant aortic insufficiency is already present, more fre-
quent monitoring is recommended [6] (see Diagnosis and Surveillance of Aortic 
Root Dilation below for more detailed guidelines).
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2.1.2 Bicuspid aortic valve
Bicuspid aortic valve is one of the most frequent congenital heart anomalies in 
adults, affecting 0.9–2% of the population [19]. Most cases of bicuspid aortic valve are 
familial and studies show that heritability of the disease is ~90% making it an auto-
somal dominant pattern with incomplete penetrance [20]. Bicuspid aortic valve can 
occur alone or with other congenital cardiovascular disorders such as coarctation of the 
aorta, supravalvular or subvalvular aortic stenosis, and ventricular septal defect [21].
The diagnosis is often established by transthoracic echocardiogram (TTE), 
which has high sensitivity (~92%) and specificity (~96%) [22]. TTE is also useful 
for surveillance of potential complications of bicuspid aorta such as aortic stenosis, 
aortic dilation, aortic regurgitation, and infective endocarditis [23]. Given the risk of 
inheritance, first degree relatives are also recommended to be screened with TTE [21].
Prevalence of aortic dilation in patients with bicuspid aortic valve disease ranges 
from 20 to 84% depending on the criteria used in different studies [24]. The risk of 
aortic dilation increases with age and the risk of dissection increases as the aortic 
diameter increases [25, 26]. When the aortic root diameter is above 4.5 cm, there is 
a family history of aortic dissection, or aortic diameter change is rapid it is recom-
mended to perform echocardiogram annually [21]. More frequent surveillance is 
recommended for patients with aortic root diameters approaching surgical thresh-
olds (see Surgical Interventions section below).
2.1.3 Loeys-Dietz syndrome
Loeys-Dietz syndrome (LDS) is a rare congenital syndrome characterized by 
hypertelorism (widely spaced eyes), a split uvula or cleft palate, tortuous arteries and 
aortic aneurysms. LDS shares many features with Marfan syndrome [14]. Most of the 
LDS cases are sporadic or show an autosomal dominant pattern of inheritance [14].
The incidence and prevalence of the disease is still not well established.
Loeys-Dietz syndrome was initially classified into two subtypes based on the 
severity of the cutaneous and craniofacial features but later was divided into six 
subtypes stratified by genotypes [27]. These subtypes are labeled 1–6 and associated 
with mutations in TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3, SMAD2, respec-
tively [27]. Type 1 and type 2 are the most commonly seen subtypes with frequen-
cies of 20 and 55% among all subtypes, respectively [28].
Patients with family history of Marfan disease
• Ectopia lentis
• Systemic score ≥ 7
• Aortic root dilatation Z-score
≥2 in patients above 20 years old
≥2 in patients below 20 years old
Patients without family history of Marfan disease
• Aortic root dilatation Z-score ≥ 2 and Ectopia lentis
• Aortic root dilatation Z-score ≥ 2 and FBN1 mutation
• Aortic root dilatation Z-score ≥ 2 and systemic score ≥ 7
• Ectopia lentis and FBN1 mutation associated with aortic root dilatation
Table 1. 
Revised Ghent nosology.
Aortic Aneurysm and Aortic Dissection
4
Aortic root dilation is a hallmark feature of this disease entity and is frequently 
seen in patients (~80%) [29]. Another vascular manifestation is aneurysms 
throughout the arterial tree. This is a concerning clinical manifestations of the 
disease and can cause aggressive arteriopathy; therefore, early operative interven-
tion at ascending aortic diameters of ≥42 mm is recommended [30].
2.1.4 Ehler-Danlos syndrome
Ehlers-Danlos syndromes (EDS) are a heterogeneous and relatively rare group of 
connective tissue disorders characterized by skin hyperextensibility, joint hypermo-
bility, and tissue fragility [31]. Ehler-Danlos syndrome can present with a variety of 
clinical manifestations and can be caused by different kinds of genetic mutations. 
Overall prevalence of EDS is ~1 in 5000 and EDS hypermobile (hEDS) is the most 
common type [31].
Vascular complications can be seen with different types of EDS; however, it 
is most commonly seen in type IV (vascular or arterial ecchymotic type; vESD), 
characterized by an autosomal dominant mutation in COL3A1 (collagen, type III, 
α-1 gene) encoding type III procollagen [32]. Up to 80% with vESD patients suffer 
from vascular complications by the age 40 years [32]. Therefore EDS patients, 
especially vEDS, patients should be routinely evaluated for aortic root disease. 
These patients are recommended to undergo elective operation at smaller diameters 
(4.0–5.0 cm) to avoid acute dissection or rupture. Patients with a growth rate of 
more than 0.5 cm/year in an aorta that is <5.5 cm in diameter are recommended to 
be considered for operation [33].
2.2 Nongenetic
2.2.1 Idiopathic
Aortic root dilation is an established phenomenon that has shown strong correla-
tions to key pathobiological factors such as age, body surface area (BSA), height and 
gender. The correlation of aortic root size with age and BSA were initially described 
in the development of screening nomograms using M-mode echocardiograms [34]. 
Follow up studies with 2D echocardiography further validated these correlations, 
allowing for the development of nomograms for normal patient populations or 
adjusted for patients with underlying congenital disorders (i.e., Marfan syndrome) 
[2, 35]. These studies evaluating AoD by echocardiograms are further supported by 
reviews of autopsy data that show clear correlations to key pathobiological factors 
such as increased age and height with AoD [36].
Despite the validation of age as being correlated strongly with AoD, the mecha-
nism of age on the development of AoD still remains an area of active research. 
One of the predominant hypotheses is based on the idea of cyclic stress, and how 
the aorta degrades through gradual mechanical decline of elastin proteins [37]. 
Elastic arteries, namely the aorta, are estimated to dilate by 10% with each beat 
[38]. It is hypothesized that the shear stress over a normal lifetime results in the 
degradation of elastic lamella, resulting in arterial dilation and stiffening [38]. This 
is corroborated by histologic data demonstrating damage to medial elastin of the 
proximal aorta [38]. Furthermore, there is evidence to suggest that in the absence 
of risk factors such as hypertension or atherosclerosis, the aortic wall undergoes 
age-associated reprograming that is proinflammatory promotes progression of arte-
rial disease [39]. Wang et al. demonstrated in pathologic samples of aortas that age 
correlated with increased smooth muscle cell invasion, and increased production of 
downstream angiotensin II mediators [39].
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In addition to age and BSA, gender is another key factor which can increase the 
risk and progression of AoD [40]. In the Framingham study of 1849 men and 2152 
women, not currently diagnosed with cardiac disease or having a cardiac history, 
aortic root was 2.4 mm smaller in women than men with m-mode echocardiography 
[40]. A systematic review in 2014 of 10,741 patients with hypertension revealed 
men had a significantly higher incidence of AoD relative to women [41].
In conclusion, a series of biological variables are correlated with AoD, and it is 
important to take these into account as they are potential confounders or contribu-
tors in the evaluation of patients with pathologic AoD. Even exercise capacity 
has been correlated with AoD, with a recent meta-analysis showing that athletes 
defined by participation in National Collegiate Athletic Association (NCAA) or 
international equivalent had an aortic root diameter that was larger than nonath-
letic controls [42], and a statistically significant increase by measurement of sinuses 
of Valsalva and aortic root annulus [42]. It is important to understand the signifi-
cance of biological variables such as age, height, BSA, or gender to fully evaluate 
pathologic AoD without the influence of known confounders.
2.2.2 HTN
Hypertension is a well-known risk factor for aortic dissection, and in some 
studies, it is estimated to factor into roughly half of the overall risk for aortic dis-
section [43]. A recent prospective cohort study of 30,447 patients, 86% of patients 
who developed aortic dissection had hypertension [4]. However the relationship 
between hypertension and AoD is not as clearly established. In a Framingham study 
of 3195 patients, there was no relationship between the development of AoD with 
hypertension [44]. A subsequent follow up study of Framingham participants 
evaluating aortic root diameter was positively correlated with mean arterial pres-
sure, but negatively associated with pulse pressure, indicating that the mechanism 
behind AoD is more complicated [45]. Moreover, investigations have shown that in 
patients with other comorbidities for AoD, such as, Turner syndrome, hyperten-
sion is significantly associated with increased prevalence of AoD [45]. This has 
led to interesting insights into the cyclic stress hypothesis of the development of 
AoD [43]. If AoD develops due to chronic shear stress, then it would be expected 
that AoD is correlated with higher pulse pressure (PP), which would presumably 
lead to greater stress and aortic dilation [43]. However, studies have reported an 
inverse relationship between AoD and PP [43]. Additionally a systematic review in 
2014 showed that in a population of 10,791 hypertensive patients, 9.1% had AoD 
with a significant gender skew toward men [41]. However there was no significant 
correlation of mean arterial pressure or pulse pressure values and AoD [41]. While 
hypertensive patients have a higher incidence of AoD, the mechanism remains to be 
further investigated. Moreover, these unclear correlations between MAP, PP, and 
AoD suggest that the aorta is not static, but a dynamic structure whose response to 
stress, such as hypertension, is still being elucidated [43].
2.2.3 Infections
Since the first mass production of penicillin in 1945, the modern era of antibiot-
ics has resulted in a decrease in the prevalence of mycotic aneurysms due to bacte-
rial infections in developed countries [46, 47]. However they can still be found in 
developing countries, and are rare but well described causes of mycotic aneurysms 
[46]. Most common pathogens include Salmonella, Staphylococcus and Streptococcus 
pneumonia, and while rare have been in the pathogenesis of mycotic aneurysms 
of the aortic root [46, 48, 49]. Other common bacteria include Mycobacterium 
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tuberculosis and Treponema pallidum, which will be discussed below, and more rare 
causes include Listeria, Bacteroides, Clostridium septicum, and Campylobacter jejuni 
[46]. With the majority of bacterial aortitis, aneurysm development is generally 
saccular, and Salmonella has been reported in case studies to predominantly affect 
the abdominal aorta than the thoracic [46, 48]. Infections with Staphylococcal 
species generally are related to underlying aortic valve infections, but have been 
reported to progress into aneurysms of the aortic root [46, 49].
2.2.3.1 Treponema pallidum
Treponema pallidum, a sexually transmitted spirochete which is the caus-
ative organism of syphilis, is a well characterized cause of aortitis [46, 50, 51]. 
Cardiovascular involvement is limited to late stage, or tertiary syphilis, and gener-
ally occurs 5 to upwards of 40 years after primary infection [50, 51]. Aortitis, and 
aneurysm development is due to invasion of the vasa vasorum, resulting in oblitera-
tive endarteritis that leads to degradation of the aortic media [50, 51]. The chronic 
inflammation results in fibrosis of the intima, a phenomenon known as “tree-
barking” that ultimately progresses to aneurysm development. In an autopsy study 
in 1960 of 51 aortic aneurysms secondary to syphilitic aortitis, 7.8% were found 
at the sinuses of Valsalva and 29.4% involved the ascending aorta, representing a 
majority of the sample [52]. This predominance to the ascending thoracic aorta have 
been further corroborated in later studies, however the detailed echocardiographic 
analysis of syphilitic aortitis, specifically in relation to AoD is limited due to the 
rarity of the disease presentation [46, 50].
2.2.3.2 Tuberculosis
Tuberculosis is a relatively common infection especially in developing coun-
tries [53]. Mycobacterium tuberculosis, the causative pathogen, is a known cause of 
mycotic aortic aneurysms [46, 50]. Pathogenesis of tuberculous mycotic aneurysm 
is believed to be due to lymphatic spread or hematogenous seeding, and mortality 
rates are reported as high as 60% in patients who develop this complication [50]. 
While more commonly affecting the distal aortic arch and descending aorta, there 
are case reports detailing aortic root aneurysms due to tuberculosis [50, 54].
2.2.3.3 HIV
There have been case reports proposing an association between aortic aneu-
rysms and HIV [50]. In a variety of these cases the causes are generally multifacto-
rial, as the majority of cases have reported coinfections (Q fever and leishmaniasis) 
or comorbid autoimmune conditions (giant cell arteritis) [55, 56]. It is still an area 
of investigation as to whether there is a true association, and there is sparse data 
showing a relationship with AoD.
2.2.4 Inflammatory disorders
2.2.4.1 Ankylosing spondylitis
Ankylosing spondylitis, a seronegative spondyloarthropathy, is a chronic, 
progressive rheumatologic disorder, and was one of the first found to be associated 
with aortitis [50, 57]. The proposed mechanism of AoD in ankylosing spondylitis is 
fibrous growth development along the intima, which leads to subsequent weaken-
ing [57]. Prior TEE studies further evaluated the prevalence of AoD in ankylosing 
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spondylitis, and 82% of patients with ankylosing spondylitis had aortic root 
abnormalities [58]. Specifically, 61% of patients had aortic root thickening and 25% 
of patients had AoD [58]. AoD in these populations is a relatively common phenom-
enon and is associated with significant cardiac morbidity [45, 57].
2.2.4.2 Relapsing polychondritis
Relapsing polychondritis is another autoimmune disorder, which is a multisys-
tem inflammatory disorder that primarily affects the cartilaginous structures of 
the body [59]. Cardiovascular involvement is common, estimated to be the second 
most frequent cause of death and can result in aneurysm development in 5% of 
cases of both thoracic and abdominal aorta [50, 59]. AoD has been known to occur, 
albeit rare, with cases of requiring surgical revision after the development of aortic 
regurgitation [60, 61].
2.2.4.3 Takayasu arteritis
Takayasu arteritis is a chronic granulomatous large vessel vasculitis, predomi-
nantly found in pediatric populations [50, 62]. A rare disorder, the pathogenesis 
is characterized by granulomatous panarteritis that can affect the entirety of the 
aorta and major branches, however predominantly affects the common carotid and 
subclavian artery [62]. While rare, there are reports of AoD from Takayasu arteritis 
resulting in aortic regurgitation [63, 64].
2.2.4.4 Giant cell arteritis
Giant cell arteritis is a large vessel vasculitis that is characterized by chronic 
granulomatous inflammation [50]. While commonly affecting carotid, temporal 
and vertebral arteries, it has been known to affect the ascending aorta, at times 
resulting in dissection or aortic valve insufficiency [50]. The development of AoD 
from GCA may be influenced by other comorbid conditions such as HIV; however, 
this association is currently only supported with case reports [55].
2.2.5 Other
2.2.5.1 Left ventricular hypertrophy
Additionally left ventricular hypertrophy is reported to be positively correlated 
with AoD. Early retrospective reviews of echocardiographic studies have shown a 
positive relationship between LVH and AoD, and this has been further supported 
in subsequent systematic reviews [41, 65]. Patients with AoD with concomitant left 
ventricular hypertrophy are shown to have an increased risk of adjusted cardiovas-
cular events [66]. However as with previous studies, the exact mechanism between 
LVH and AoD is still being determined.
3. Diagnosis and surveillance of aortic dilation
3.1 Clinical manifestations
Aortic root dilation is typically a silent disease, with most cases being diagnosed 
incidentally on imaging. AoD can become symptomatic as the aneurysm enlarges. 
Aortic root aneurysms grow at an average of 1–4 mm/year [5], with a faster rate 
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of growth noted in patients with bicuspid aortic valves, Marfan syndrome, ESRD, 
male gender, and smokers [5, 67]. When the aneurysm enlarges to the point of 
compressing surrounding structures the patient may begin to observe symptoms—
the most common of which is chest pain, seen in up to 75% of patients [5, 68]. Other 
nonspecific symptoms can include back pain, abdominal pain and fatigue (though 
only present in 5% of patients).
Additionally, patients may present with symptoms secondary to complications 
of a dilated aortic root such as aortic insufficiency and congestive heart failure. 
Thus, patients can develop dyspnea as the presenting symptom of aortic root dila-
tion up to 40% of the time [68]. Other presenting symptoms may be related to the 
complications noted in Table 2 [69–74].
3.1.1 Complications of aortic root dilation
Acute aortic emergencies that occur secondary to aortic root dilation include dissec-
tion, rupture, and aortic insufficiency. As the aortic root diameter increases, the risk 
for aortic dissection and rupture rises [75]. Aortic dissections are the most common 
acute aortic emergencies [76], and can be classified depending on the segment of the 
aorta affected: type A dissections involve the ascending aorta (seen in aortic root dila-
tion), while type B dissections are those that occur distal to the left subclavian artery.
Aortic dissection most commonly presents with acute onset chest pain that may 
radiate to the back. The character of the pain has traditionally been described as 
ripping or tearing in nature, however over half of patients may instead complain 
of sharp pain [77]. In addition, geriatric populations are less likely to have an acute 
onset of pain [78]. Physical exam findings that may be present include unequal blood 
pressures in the upper extremities, a new diastolic murmur indicative of acute aortic 
regurgitation, or muffled heart sounds secondary to tamponade (with proximal 
extension of the dissection). Imaging may be notable for widening of the mediasti-
num on CXR [77]. In order to aid in the diagnosis of a dissection, an aortic dissec-
tion detection risk score (ADD-RS) has been developed. The score is comprised of 
three categories: the presence of high risk conditions such as Marfan syndrome, the 
presence of typical symptoms (such as abrupt onset chest pain), and the presence of 
physical exam findings such as unequal blood pressure readings in the upper extrem-
ities. Each group is given a score of 1 if a feature is present, and the total score helps 
pave the next steps of workup—a score of 0 can be followed by diagnostic workup of 
other pathologies, while scores of 2–3 should be followed by expedited workup and 
immediate surgical consultation for possible aortic dissection [79].
Complication of aortic root aneurysm Presenting symptom
Aortic insufficiency, aortic regurgitation Dyspnea, diastolic murmur, congestive heart failure 
symptoms
Aortic dissection Sharp chest pain, may radiate to the back
Thromboembolism Symptoms of stroke
Compression of tracheal or bronchus Hemoptysis, cough, recurrent pneumonitis
Compression of left recurrent laryngeal nerve Hoarseness
Compression of superior vena cava Signs of superior vena cava syndrome
Compression of esophagus Dysphagia
Table 2. 
Complications and presenting symptoms of aortic root dilation.
9Diagnosis and Surveillance of Aortic Root Dilation
DOI: http://dx.doi.org/10.5772/intechopen.86329
Aortic rupture is also an acute and life-threatening complication of aortic root 
dilation. It can present similarly to aortic dissection with regards to chest pain, 
however rupture can lead to severe and abrupt hypotension. Moreover, contingent 
with the site of rupture the patient may have symptoms such as hemoptysis [80] 
(if there is rupture into the lung), hematemesis [81] (if there is rupture into the 
esophagus), or cardiogenic shock [82] (if there is rupture into the pericardial cavity 
with resultant tamponade physiology).
Aortic root dilation may also lead to aortic insufficiency. Roughly 30% of aortic 
insufficiency is now recognized as being caused by aortic root dilation, surpassing 
the incidence of any valvular cause [83]. The pathophysiology is related to stretch-
ing of the aortic valve annulus secondary to aortic root dilation, which results in 
incomplete closure of the aortic leaflets during diastole. Unfortunately, at the onset 
of aortic regurgitation, patients may be asymptomatic; therefore, congestive heart 
failure can develop when the regurgitant valve goes unnoticed.
3.1.2 Impact/burden on public health
While aortic root aneurysms are known to grow at an average of 1–4 mm/year 
[5], it is difficult to ascertain how fast an individual’s aortic root aneurysm will 
grow, therefore necessitating surveillance imaging. The frequency of surveillance 
imaging recommended is dependent on the etiology of the aortic root dilatation as 
well as its size, with genetically mediated aortic disease having a lower threshold 
for more frequent (biannual) imaging [84]. At the very least however patients are 
recommended to have annual imaging for aortic root dilation to closely monitor the 
aortic diameter. The impact that frequent imaging (CT, MR angiography or echo-
cardiography) has on public health is likely significant, with cumulative costs. In 
addition, any patient with a bicuspid aortic valve should be screened for a thoracic 
aortic aneurysm, as well as screening all first-degree family members of a patient 
with genetic conditions such as Marfan syndrome [85].
3.2 Noninvasive imaging
The aortic root is the most proximal segment of the aorta. It extends from the 
annulus of the aortic valve to the sinotubular junction (STJ). It is composed of 
the left, right, and non coronary sinuses of Valsalva. The diameter of the aorta 
decreases as it moves distally. The aortic root is assessed using multimodality imag-
ing techniques. These include transthoracic echocardiogram (TTE), cardiac mag-
netic resonance imaging (cMRI), and cardiac computed tomography angiography 
(cCTA).
3.2.1 Transthoracic echocardiogram
TTE is widely used for the detection and monitoring of aortic root pathology. 
Early studies established age- and sex-specific nomograms for aortic root mea-
surements [86]. These studies used the motion mode (M-mode) of TTE, in which 
the amplitude of the ultrasound pulses amplitudes is converted to corresponding 
level on gray-scale imaging [86]. Using the M-mode, the American Society of 
Echocardiography (ASE) has recommended using the leading-edge to leading-
edge approach for measuring the aortic root [87]. Later studies used 2D TTE and 
obtained reference measurements of the aortic root. This is now preferred over 
M-mode images, which may be off-axis and are subject to aortic motion that may 
produce erroneous measurements.
Aortic Aneurysm and Aortic Dissection
10
On echocardiogram, the aortic root diameter is typically measured in the 
parasternal long-axis view from the right coronary sinus to the opposite sinus 
of Valsalva. When unable to obtain the long axis view, the parasternal short axis 
view may provide more accurate measurements. However, universal landmarks 
to measure the root in this view have not been established. Some suggest measur-
ing the diameter from the right coronary sinus to the opposite commissure. These 
measurements are typically performed at end diastole, as this represents the resting 
aortic diameter [88]. In adults, these measurements correlate with age and body 
size. In addition, the aorta is about 2 mm larger in men compared to women due to 
differences in body size [89]. Normal values stratified by body surface area and age 
have been published by the ASE [87].
Importantly, TTE is limited by its two-dimensional images and thus does not give 
a complete depiction of the aortic root. It is also limited by patient factors that limit 
the visualization windows and thus aortic root measurement. Since the aorta is not a 
straight tube, it can be imaged obliquely leading to over-estimation of its true diam-
eter. Newer modalities, such cMRI and cCTA, can provide three-dimensional images.
3.2.2 Cardiac magnetic resonance imaging
Despite ECG-gated CT being the most accurate modality for evaluating the thoracic 
aorta, it is limited by the radiation and contrast exposure. This is particularly impor-
tant in younger patients with connective tissue disorders that require serial follow up 
imaging. Cardiac MRI provides an alternative approach for imaging the thoracic aorta 
including the aortic root and is considered the preferred modality in select groups. It 
can be performed with ECG gating to provide motion-free evaluation of the aorta. In 
addition, young patients, in whom this is more commonly used, can hold their breath 
for longer periods, allowing acquisition of images with high spatial resolution.
Cardiac MRI evaluation of the aorta does not require contrast use. MRI 
sequences used include balanced steady-state free precession (SSFP) sequences, 
fast imaging employing steady-state acquisition (FIESTA), true fast imaging with 
steady-state precession (FISP), and balanced fast-field echo (FFE) sequences. These 
sequences provide a high signal-to-noise ratio and adequate contrast between vessel 
wall and blood pool [90]. When used with ECG gating and contrast enhanced 
MRA, images tend to have less artifact, higher resolution, and overall short imaging 
time. Another approach is to use ECG gating 2D balanced SSFP sequence that is 
oriented perpendicular to the aortic root in two planes to assess the aortic valve and 
root throughout the cardiac cycle. In addition, prospective ECG gating and respira-
tory navigation with three-dimensional balanced SSFP sequences can provide 3D 
aortic imaging without contrast administration [91, 92].
It is important to note that different methods of aortic measurement have been 
described and guidelines are less well defined. Aortic root measurements can be 
challenging given different approaches. Burman et al. found in the Framingham 
Heart Study that cusp-commissure dimensions better corresponded with reference 
echocardiographic aortic root measurements [89, 93]. This best correlated with 
study measurements after averaging the three end-diastolic cusp-commissure mea-
surements [93]. In addition, there is a lack of consensus with regard to measure-
ments used (inner lumen only versus lumen and wall) and whether measurements 
should be adjusted to body surface area, sex, and age.
3.2.3 Cardiac computed tomography
Although TTE is widely used for the imaging and surveillance of aortic root, car-
diac computed tomography angiography (cCTA) is currently the most commonly 
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used technique for the study of the thoracic aorta. Main advantages of cCTA are fast 
scanning times, low artifact sensibility, and wide availability including emergency 
rooms operating 24 h [94].
The new generation CT scanners acquire high-resolution 3D datasets of the 
thoracic aorta, showing sensitivities up to 100% and specificities of 98–99% [95]. 
ECG synchronization is vital for detailed assessment of the aortic root anatomy 
since it allows suppression of pulsation artifacts [96]. ECG gating also allows view-
ing images in a particular phase of the cardiac cycle. Unfortunately, the ECG-gated 
technique can increase the acquisition time and required breath-hold time. In order 
to minimize the increased acquisition times, employment of a 64 or wider ECG-
gated row detector system is suggested [95, 97].
Modern CT scanners can be used to employ several different cardiac synchroni-
zation methods such as prospective ECG triggering where images are only acquired 
during a specified portion of the cardiac cycle, starting at a predetermined delay 
from the R wave; retrospective ECG gating where the desired cardiac phase is 
selected retrospectively from the raw data [95, 97]. The details of each technique 
will not be discussed in this chapter; however, it is important to determine the 
advantages and disadvantages of different techniques. The main limitations of CT 
are related to the radiation exposure and the use of iodinated contrast media and 
different techniques come at a higher cost of each limitation.
For the surveillance of aortic root, any technique can be used and be useful; 
therefore, the technique with the least amount of radiation exposure should be 
selected such as prospective sequential triggering without padding, retrospective 
gating with tube-current modulation optimized for diastolic-phase datasets only, or 
a prospectively triggered high-pitch helical acquisition [95, 97]. Retrospective ECG 
gating acquires redundant helical CT data which allows the reconstruction of images 
at different cardiac phases and providing detailed images which can be useful in com-
plicated cases and pre-/post-operative imaging since pseudoaneurysm or small leaks 
which are some of the most common complications of aortic root surgery can only 
be detected during a specific phase of the cardiac cycle. Iodinated contrast-media is 
another risk related to CT imaging given the risk of contrast induced nephropathy 
and allergic reactions of various severity. Surveillance CT data for the dimensions of 
aortic root can be acquired without contrast injection; however, a complete endolu-
minal evaluation can only be achieved by the injection of contrast-medium [97].
It is standard of care to monitor the size of aortic aneurysms that are below 
surgical threshold, <5.5 cm for nongenetic aneurysms and <5.0 cm for genetically-
mediated aneurysms [98]. In general, physicians should be conscientious about 
patient cumulative radiation exposure as there is evidence that it can increase cancer 
incidence and cancer mortality [99]. One study estimated that ionizing radiation 
exposure results in 0.7% of total expected baseline cancer incidence and 1% of 
total cancer mortality. These rates increase with greater cumulative exposure [99]. 
Therefore, physicians should opt to perform serial CT imaging with longer intervals 
in the most appropriate patients. A study investigating patients with moderate-risk 
thoracic aortic aneurysms (defined as size <5.0 cm) showed that patients with 
aneurysms below 4.3 cm had overall lower risk of significant aneurysm growth or 
size reaching surgical threshold. Thus, the authors suggested that these subset of 
patients undergo surveillance CT scans less frequently.
4. Management and prevention of aortic root dilation
Management focuses on slowing the rate of growth and the complications of 
aortic root dilation. The line of management that is chosen for a patient depends on 
Aortic Aneurysm and Aortic Dissection
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symptoms and size of the aneurysm. For patients who are asymptomatic and have 
root dilation <55 mm, medical management is advised. In patients with Marfan 




The use of beta blockers has shown a survival benefit in patients with aortic 
root dilation secondary to Marfan syndrome [101]. While data on survival benefits 
for patients with bicuspid aortic valves is sparse, the common practice is to also 
prescribe beta blockers given that both conditions share a similar pathology and 
therefore both are likely to benefit from beta blockade. The mechanism by which 
beta blockers slow the progression of aortic root dilation is through their negative 
inotropic and chronotropic effects, reducing the peak left ventricular ejection rate 
and therefore decreasing shear stress and the rate of aortic dilation [102].
4.1.2 Other agents for blood pressure control
The goal blood pressure for patients with thoracic aortic aneurysms is 
<130/80 mmHg. In patients who cannot tolerate beta blockers, calcium channel 
blockers (CCB) are an alternative group of medications available. While less studied 
as compared to beta blockers, CCB have also been found to reduce the rate of aortic 
root dilation [103]. Other agents that can be used for additional blood pressure 
control include ACE-inhibitors and ARBs.
4.1.3 Management of other cardiovascular risk factors
In order to reduce the risk for complications such as aortic dissection, patients 
should be counseled on smoking cessation, and cessation of drugs that increase aor-
tic wall stress such as cocaine or other stimulants. In addition patients should have 
dyslipidemia well controlled, which can be achieved through the use of atorvastatin 
40–80 mg daily in individuals with aortic root aneurysms [104, 105].
4.1.4 Lifestyle modifications and pregnancy
Patients should be counseled on avoiding high intensity and collision sports, such 
as boxing and cycling. Instead patients should take part in low dynamic sports, such 
as, golf [5, 106]. Pregnancy should be avoided in patients with Marfan syndrome with 
an aortic diameter >40 mm, if a patient does chose to become pregnant however there 
must be close follow up with surveillance imaging of the aortic diameter [5, 101].
4.2 Surgical management
4.2.1 Indications for surgery
Emergent surgical interventions are indicated for management of an aortic 
dissection or rupture, or a symptomatic aneurysm. In addition, surgical repair can 
be performed electively in high risk patients to prevent propagation of an aneurysm 
(Table 3). Indications for elective surgical intervention include the absolute size of 
the aneurysm—if the diameter is over 55 mm, or over 50 mm in patients with Marfan 
syndrome or bicuspid valves. Other indications for elective surgery include if the rate 
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of growth of an aneurysm surpasses 10 mm/year, and if there is concurrent aortic 
insufficiency [1, 100]. In addition, patients who undergo aortic insufficiency repair 
who have concurrent aortic root dilation should be considered for aortic replacement 
at the time of their surgery—that is since 25% of patients with aortic root diameters 
>40 mm will eventually also require intervention for their aortic aneurysm [107].
4.2.2 Surgical interventions
As opposed to supravalvular aortic aneurysms, aortic root aneurysms involve 
the coronary ostia as well as the aortic valve, which have implications on the type 
of surgical procedure available for patients. There are two approaches for a surgical 
intervention: radical and conservative. In a radial surgical intervention the patient’s 
aortic valve and root are replaced (commonly referred to as the Bentall procedure), 
whereas in conservative interventions only the aortic root is replaced [108].
The Bentall procedure involves replacing the aortic valve with a prosthetic valve, 
and thus has the caveat of requiring indefinite anticoagulation [5]. If patients have 
a high bleeding risk it may therefore be worthwhile investigating replacement of 
the aortic root while preserving the valve. In addition, it is important to note that 
a large number of patients with aortic root dilation are young (secondary to its 
association with Marfan syndrome), and therefore lifelong anticoagulation in cases 
such as these confers a cumulative bleeding risk. Preserving the aortic valve while 
surgically treating the aortic root dilatation is made possible by the development 
of two surgical procedures: the first is removing the aortic root while keeping the 
valve intact. The second method is through re-implantation of the aortic valve 
[5]. Both the Bentall procedure as well as aortic valve-preserving procedures have 
been shown to have comparable short and long-term outcomes with regards to the 
risk of death and valve associated complications. The main difference however is 
that patients undergoing valve sparing operations were significantly more likely to 
develop moderate to severe aortic regurgitation later [108].
In patients with both severe aortic stenosis and ascending aortic aneurysm, 
undergoing surgical aortic valve replacement (sAVR) and concomitant surgical 
intervention for aortic aneurysms above 4.5 cm is recommended by the American 
College of Cardiology (ACC) foundation guidelines [84]. However, in high-risk 
surgical patients, undergoing a transcatheter aortic valve replacement (TAVR) has 
become an alternative approach that obviates the need for parallel surgical aortic 
aneurysm intervention. This raises the concern for the safety of TAVR catheter-
based delivery system in patients with aortic aneurysms since intraoperative rup-
ture or dissection risk potentially increases. However, a clinical study showed that 
TAVR does not increase intraoperative aortic dissection/rupture risk or mortality 
with a median follow-up of 14 months [109]. Therefore, there are no recommenda-
tions against performing TAVR in patients with ascending aortic aneurysms.
Emergent surgical repair Elective surgical repair
• Aortic rupture
• Aortic dissection
• Symptomatic aortic root dilation (may 
represent an impeding rupture)
• Aortic dilation >55 mm
• Aortic dilation >50 mm in individuals with Marfan 
syndrome or bicuspid valves
• Rate of growth >10 mm/year
• Aortic insufficiency (decision largely based on 
diameter of aortic dilation)
Table 3. 
Indications for emergent and elective surgical repair of aortic root dilation.
Aortic Aneurysm and Aortic Dissection
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